Which antipsychotic is noted to be administered SQ only?

The correct answer, Perseris, is an atypical antipsychotic designed specifically for subcutaneous (SQ) administration. This formulation is beneficial for providing a consistent release of medication over time, allowing for less frequent dosing compared to oral forms. Perseris, which contains the active ingredient risperidone, is formulated as a slow-release injectable, making it ideal for patients who may have difficulties with adherence to oral medications or who require a stable concentration of the drug to manage their symptoms effectively.

In contrast, the other options—Geodon, Risperdal, and Abilify—are available in various formulations, including oral tablets and intramuscular injections, but do not have a specific formulation or approval for subcutaneous administration as Perseris does. This highlights the unique delivery method of Perseris within the context of antipsychotic medications.